RJA
RETA

Raymond James & Associates’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Raymond James & Associates’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,156
Closed -$744K – 3545
2020
Q1 		$744K Buy
5,156
+3,106
+152% +$448K ﹤0.01% 2163
2019
Q4 		$419K Sell
2,050
-2,240
-52% -$458K ﹤0.01% 2843
2019
Q3 		$344K Buy
4,290
+150
+4% +$12K ﹤0.01% 2908
2019
Q2 		$391K Buy
+4,140
New +$391K ﹤0.01% 2826